ACT-TIL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACT-TIL, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: ACT-TIL and ANV419 for Advanced Melanoma. [Phase 1]